Mallinckrodt plc has announced plans to acquire Stratatech Corporation, a regenerative medicine company that develops proprietary skin substitute products.
The acquisition is expected to strengthen Mallinckrodt’s overall business.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Scintilla Pharmaceuticals Inc, a subsidiary of Sorrento Therapeutics Inc, has announced the acquisition of pharmaceutical company Semnur Pharmaceuticals Inc for a purchase consideration of up to $200m.
Scintilla is a provider of the resiniferatoxin programme for the treatment of opiate refractory cancer pain. The transaction is expected to help Scintilla to expand its pain management pipeline.
Lonza Group Ltd has acquired InterHealth Nutraceuticals Inc, a provider of nutritional ingredients for use in dietary supplements, for $300m.
The acquisition is expected to help Lonza to support its nutritional ingredients portfolio and also expand its business into the cognitive and diabetic health segments.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataActive With Me Inc has merged with Rasna Therapeutics Inc in a reverse takeover transaction. The new company will be named as Rasna Therapeutics Inc.
SASMAR Pharmaceuticals S.P.R.L. has announced the acquisition of Aquatrove Biosciences through its Australian subsidiary SASMAR Healthcare Pty Ltd.
Aquatrove is a biotechnology company focused on the human reproductive health and fertility areas. The transaction is expected to strengthen Sasmar’s product pipelines and build its position in over-the-counter products in the health, fertility and reproduction segments.
